Capital Fund Management S.A. Intra Cellular Therapies, Inc. Transaction History
Capital Fund Management S.A.
- $37.9 Billion
- Q4 2024
A detailed history of Capital Fund Management S.A. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 37,513 shares of ITCI stock, worth $4.92 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,513
Previous 26,093
43.77%
Holding current value
$4.92 Million
Previous $1.91 Million
64.29%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ITCI
# of Institutions
418Shares Held
88.6MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$830 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$673 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$426 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$422 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...